Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Baricitinib may effectively treat nail changes in alopecia areata.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Phosphatidic acid may promote hair growth like minoxidil.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Drugs like PDEI may help hair disorders like AGA.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Baricitinib can cause excessive hair growth.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

Tigason improved hair growth in a boy with monilethrix without side effects.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

GD-23 reduces anxiety by relying on neurosteroid production.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

JAK inhibitors are effective for long-term management of alopecia areata.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Curcuma aeruginosa Roxb. may help treat hair loss by affecting specific biological pathways.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.